We also cover the STOMP trial (do statins actually impair strength gains?), the SAMSON trial (how much of statin intolerance is nocebo?), the difference between myalgia, myositis, and rhabdomyolysis, Austins clinical approach to a patient whose strength is declining on a statin, and the treatment escalation pathway for statin-intolerant patients including bempedoic acid, PCSK9 inhibitors, and inclisiran
GHK-Cu serves as a research-relevant copper delivery vehicle
Until then, we are not impressed
Tirzepatide vial sizes and standard doses align so that you use the entire vial before the reconstituted solution expires
The purchaser is responsible for using and storing the product appropriately and in accordance with applicable regulations
Setting Realistic Expectations: Timeline and Markers This is not a quick fix